Y. Takeuchi

发表

Acetyl tributyl citrate, the most widely used phthalate substitute plasticizer, induces cytochrome p450 3a through steroid and xenobiotic receptor.

A. Takeshita, N. Koibuchi, Junko Igarashi-Migitaka, 2011, Toxicological sciences : an official journal of the Society of Toxicology.

Effects of 1-year treatment with fluvastatin or pravastatin on bone.

Y. Takeuchi, S. Watanabe, S. Fukumoto, 2001, The American journal of medicine.

Romosozumab and cardiovascular safety in Japan

Y. Takeuchi, 2021, Osteoporosis and sarcopenia.

FGF‐23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis

Y. Takeuchi, T. Shimada, T. Muto, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Relationship between actions of transforming growth factor (TGF)‐β and cell surface expression of its receptors in clonal osteoblastic cells

Y. Takeuchi, S. Fukumoto, Y. Takeuchi, 1995, Journal of cellular physiology.

The Primary Calcification in Bones Follows Removal of Decorin and Fusion of Collagen Fibrils

Y. Takeuchi, N. Amizuka, H. Ozawa, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Executive summary of clinical practice guide on fracture risk in lifestyle diseases

H. Hagino, M. Inaba, Y. Takeuchi, 2020, Journal of Bone and Mineral Metabolism.

Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.

Y. Takeuchi, T. Fujita, S. Fukumoto, 2002, The Journal of clinical endocrinology and metabolism.

Long-term safety of eldecalcitol in Japanese patients with osteoporosis: a retrospective, large-scale database study

Y. Takeuchi, Tomohiro Yamaguchi, M. Makishima, 2022, Journal of Bone and Mineral Metabolism.

Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period

R. Eastell, J. S. San Martin, S. Ralston, 2019, Calcified Tissue International.

Interim Analysis of a Phase 2 Open‐Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor‐Induced Osteomalacia

Yutaka Takahashi, Y. Takeuchi, C. Shin, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Clinical performance of a novel chemiluminescent enzyme immunoassay for FGF23

K. Ozono, Y. Takeuchi, S. Kitanaka, 2021, Journal of Bone and Mineral Metabolism.

[Treatment of osteoporosis with PTH].

Y. Takeuchi, 2014, Clinical calcium.

High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease.

A. Takeshita, T. Sano, S. Yamada, 2009, European journal of endocrinology.

Safety of 3-year raloxifene treatment in Japanese postmenopausal women aged 75 years or older with osteoporosis: a postmarketing surveillance study

Y. Takeuchi, H. Sowa, Masanori Taketsuna, 2015, Menopause.

Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways

Kozo Nakamura, Y. Terauchi, T. Kadowaki, 2006, Journal of cellular biochemistry.

Effectiveness of monthly intravenous ibandronate injections in a real-world setting: Subgroup analysis of a postmarketing observational study

Y. Takeuchi, M. Kumagai, J. Hashimoto, 2019, Osteoporosis and sarcopenia.

Safety and effectiveness of monthly intravenous ibandronate injections in a prospective, postmarketing, and observational study in Japanese patients with osteoporosis

T. Tamura, Y. Takeuchi, J. Hashimoto, 2018, Osteoporosis and sarcopenia.

The Asian Federation of Osteoporosis Societies' call to action to improve the undertreatment of osteoporosis in Asia

Ye-Soo Park, Y. Takeuchi, S. Yeap, 2017, Osteoporosis and sarcopenia.

[Endocrine diseases: progress in diagnosis and treatments. Topics: IX. Recent topics; 1. How to prevent fracture with antiosteoporosis drugs: an update].

Y. Takeuchi, 2014, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Decrease in serum leptin by troglitazone is associated with preventing bone loss in type 2 diabetic patients

Y. Takeuchi, Sumiyo Watanabe, T. Fujita, 2003, Journal of Bone and Mineral Metabolism.

How different is the once-weekly teriparatide from the daily one or the same?

Y. Takeuchi, 2019, Osteoporosis and sarcopenia.

Recent Progress in the Development of Osteoporosis Drugs

Y. Takeuchi, 2018 .

Renal Phosphate Reabsorption is Correlated with the Increase in Lumbar Bone Mineral Density in Patients Receiving Once-Weekly Teriparatide

Toshitaka Nakamura, Y. Takeuchi, T. Sugimoto, 2015, Calcified Tissue International.

New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide

Sakae Tanaka, T. Adachi, J. Bilezikian, 2014, Bone Research.

[Endocrine disease: progress in diagnosis and treatment. Topics: II. Progress in treatment; 5. Role of parathyroid hormone in bone metabolism and its clinical implication].

Y. Takeuchi, 2012, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Systemic Control of Bone Formation

Toshio Matsumoto, Y. Takeuchi, 1998 .

Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro.

E. Ogata, Y. Takeuchi, S. Fukumoto, 2000, Biochemical and biophysical research communications.

Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension

R. Eastell, S. Ralston, M. Brandi, 2021, RMD Open.

High incidence of obesity and elevated serum immunoreactive insulin level in patients with paravertebral ligamentous ossification: A relationship to the development of ectopic ossification

Toshio Matsumoto, Y. Hoshino, Y. Takeuchi, 1989, Journal of Bone and Mineral Metabolism.

Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans

S. Takeda, Y. Takeuchi, T. Fujita, 2007, Journal of Bone and Mineral Metabolism.

Low insulin resistance after surgery predicts poor GH suppression one year after complete resection for acromegaly: a retrospective study.

S. Yamada, Y. Takeuchi, H. Nishioka, 2016, Endocrine journal.

Ketoacidosis as the initial clinical condition in nine patients with acromegaly: a review of 860 cases at a single institute.

S. Yamada, Y. Takeuchi, H. Nishioka, 2013, European journal of endocrinology.

after successful pituitary surgery if pancreatic β-cell function is preserved

S. Yamada, Y. Takeuchi, H. Fujii, 2011 .

Ghrelin Directly Regulates Bone Formation

S. Takeda, K. Kangawa, H. Ishikawa, 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Clinical Challenges in Diagnosis, Tumor Localization and Treatment of Tumor‐Induced Osteomalacia: Outcome of a Retrospective Surveillance

M. Nangaku, K. Ohnaka, Y. Takeuchi, 2022, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effect of a Multifactorial Intervention on Fracture in Patients With Type 2 Diabetes: Subanalysis of the J-DOIT3 Study

Y. Ohashi, T. Kadowaki, Takayoshi Sasako, 2021, The Journal of clinical endocrinology and metabolism.

Mitotane induces CYP3A4 expression via activation of the steroid and xenobiotic receptor.

A. Takeshita, N. Koibuchi, Junko Igarashi-Migitaka, 2013, The Journal of endocrinology.

Parathyroid Hormone‐Related Protein Induced Coupled Increases in Bone Formation and Resorption Markers for 7 Years in a Patient With Malignant Islet Cell Tumors

Y. Takeuchi, T. Fujita, S. Fukumoto, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.

T. Yoneya, Y. Takeuchi, K. Okawa, 2002, Endocrinology.

GH deficiency in patients after cure of acromegaly by surgery alone.

S. Yamada, Y. Takeuchi, H. Nishioka, 2011, European journal of endocrinology.

Vitamin D insufficiency underlies unexpected hypocalcemia following high dose glucocorticoid therapy.

Y. Takeuchi, K. Masuoka, S. Miyakoshi, 2008, Bone.

Symptomatic hyponatremia after voluntary excessive water ingestion in a patient without psychiatric problems.

Y. Takeuchi, A. Takeshita, R. Hiramatsu, 2007, Endocrine journal.

Targeted ablation of Fgf 23 demonstrates an essential physiological role of FGF 23 in phosphate and vitamin D metabolism

Y. Takeuchi, T. Shimada, T. Fujita, 2004 .

Reduced Expression of Interleukin‐11 in Bone Marrow Stromal Cells of Senescence‐Accelerated Mice (SAMP6): Relationship to Osteopenia with Enhanced Adipogenesis

Toshio Matsumoto, Y. Takeuchi, T. Fujita, 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Association between activating mutations of calcium-sensing receptor and Bartter's syndrome

Y. Takeuchi, Sumiyo Watanabe, T. Fujita, 2002, The Lancet.

Inactivating Mutations of Calcium-Sensing Receptor Results in Parathyroid Lipohyperplasia

Y. Takeuchi, T. Fujita, S. Fukumoto, 2001, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 Study

R. Eastell, S. Ralston, M. Brandi, 2022, Calcified Tissue International.

Central control of bone remodeling by neuromedin U

Takahiro Matsumoto, S. Takeda, S. Kato, 2007, Nature Medicine.

FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.

T. Yoneya, Y. Takeuchi, T. Shimada, 2004, Biochemical and biophysical research communications.

[Endocrine and Metabolic Emergencies: Points of Initial Management. Topics: IV. Emergency medical care for patients with hypercalcemia or hypocalcemia].

Y. Takeuchi, Yasuhiro Takeuchi, 2016, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

GH-induced LH hyporesponsiveness as a potential mechanism for hypogonadism in male patients with acromegaly.

S. Yamada, N. Koibuchi, H. Watada, 2021, Endocrine journal.

Pathogenesis and diagnostic criteria for rickets and osteomalacia—proposal by an expert panel supported by the Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research, and the Japan Endocrine Society

Toshio Matsumoto, K. Ozono, Y. Takeuchi, 2015, Journal of Bone and Mineral Metabolism.

Comparison of two assays for fibroblast growth factor (FGF)-23

Y. Takeuchi, T. Fujita, S. Fukumoto, 2005, Journal of Bone and Mineral Metabolism.

Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia.

Kozo Nakamura, Sayoko Ogura, Y. Takeuchi, 2004, The Journal of clinical endocrinology and metabolism.

Decreased AP‐1 Activity and Interleukin‐11 Expression by Bone Marrow Stromal Cells May Be Associated With Impaired Bone Formation in Aged Mice

Toshio Matsumoto, N. Yamamoto, Y. Takeuchi, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effectiveness of bisphosphonate combined with activated vitamin D in patients with aromatase inhibitor-induced osteoporosis after breast cancer operation

S. Itoh, Y. Takeuchi, Mizue Tanaka, 2018, Osteoporosis and sarcopenia.

Surgical management and outcomes in patients with Cushing disease with negative pituitary magnetic resonance imaging.

S. Yamada, Y. Takeuchi, N. Inoshita, 2012, World neurosurgery.

Fibroblast growth factor (FGF)23 in patients with acromegaly.

S. Yamada, Y. Takeuchi, T. Fujita, 2007, Endocrine journal.

The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease.

M. Komada, S. Yamada, Y. Takeuchi, 2016, European journal of endocrinology.

The USP 8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing ’ s disease

M. Komada, S. Yamada, Y. Takeuchi, 2015 .

methyltransferase expression in invasive macroadenomas of Cushing's disease

T. Sano, S. Yamada, K. Ohashi, 2009 .

Pathogenesis and diagnostic criteria for rickets and osteomalacia - proposal by an expert panel supported by Ministry of Health, Labour and Welfare, Japan, The Japanese Society for Bone and Mineral Research and The Japan Endocrine Society.

Toshio Matsumoto, K. Ozono, Y. Takeuchi, 2015, Endocrine journal.

Runx1 and Runx2 cooperate during sternal morphogenesis

S. Takeda, S. Iseki, T. Imamura, 2010, Development.

A family of autosomal dominant hypocalcemia with an activating mutation of calcium-sensing receptor gene.

Y. Takeuchi, Sumiyo Watanabe, T. Fujita, 2003, Endocrine journal.

Clonal endothelial cells produce humoral factors that inhibit osteoclast-like cell formation in vitro.

T. Tsuruo, N. Fujita, Y. Takeuchi, 2002, Endocrine journal.

Ultrasonographic evaluation of parathyroid hyperplasia in multiple endocrine neoplasia type 1: Positive correlation between parathyroid volume and circulating parathyroid hormone concentration

Y. Takeuchi, A. Takeshita, M. Miyakawa, 2015, Journal of Bone and Mineral Metabolism.

Focal Adhesion Kinase Activity Is Required for Bone Morphogenetic Protein—Smad1 Signaling and Osteoblastic Differentiation in Murine MC3T3‐E1 Cells

K. Miyazono, Y. Takeuchi, S. Fukumoto, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Pasireotide-resistant Refractory Cushing's Disease without Somatostatin Receptor 5 Expression

S. Yamada, Y. Takeuchi, N. Inoshita, 2021, Internal medicine.

Cinacalcet hydrochloride relieves hypercalcemia in Japanese patients with parathyroid cancer and intractable primary hyperparathyroidism

Y. Takeuchi, Y. Tominaga, M. Katagiri, 2017, Journal of Bone and Mineral Metabolism.

[111th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: 17. Emerging clinical questions of calcium metabolism disorders and promising therapeutic approaches to them].

Y. Takeuchi, 2014, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Renal Phosphate Reabsorption is Correlated with the Increase in Lumbar Bone Mineral Density in Patients Receiving Once-Weekly Teriparatide

Toshitaka Nakamura, Y. Takeuchi, T. Sugimoto, 2015, Calcified Tissue International.

Immunohistochemistry or Molecular Analysis: Which Method Is Better for Subtyping Craniopharyngioma?

S. Yamada, K. Yoshimoto, Y. Takeuchi, 2020, Endocrine Pathology.

A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia.

Y. Totsuka, Y. Takeuchi, T. Fujita, 1999, The Journal of clinical endocrinology and metabolism.

An updated hip fracture projection in Asia: The Asian Federation of Osteoporosis Societies study

C. Cheung, Y. Takeuchi, U. Jaisamrarn, 2018, Osteoporosis and sarcopenia.

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

S. Takeda, S. Mizutani, T. Yoneya, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Receptor Tyrosine Kinases Inhibit Bone Morphogenetic Protein‐Smad Responsive Promoter Activity and Differentiation of Murine MC3T3‐E1 Osteoblast‐like Cells

K. Miyazono, G. Rodan, Y. Takeuchi, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

A microRNA regulatory mechanism of osteoblast differentiation

S. Takeda, H. Ochi, Shingo Sato, 2009, Proceedings of the National Academy of Sciences.

Interleukin-11 as a Stimulatory Factor for Bone Formation Prevents Bone Loss with Advancing Age in Mice*

S. Takeda, G. Ishii, Toshio Matsumoto, 2002, The Journal of Biological Chemistry.

Stimulation of Smad1 Transcriptional Activity by Ras‐Extracellular Signal‐Regulated Kinase Pathway: A Possible Mechanism for Collagen‐Dependent Osteoblastic Differentiation

K. Miyazono, S. Kato, Y. Takeuchi, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Thiazolidinediones Inhibit Osteoclast-Like Cell Formation and Bone Resorption in Vitro1.

Y. Takeuchi, M. Miyamoto, T. Fujita, 1999, Endocrinology.

Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro.

K. Miyazono, N. Ueno, S. Kato, 1999, Endocrinology.

Thiazolidinediones Inhibit Osteoclast-Like Cell Formation and Bone Resorption in Vitro *

Y. Takeuchi, M. Miyamoto, S. Fukumoto, 1999 .

Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.

Y. Takeuchi, T. Shimada, T. Fujita, 2004, The Journal of clinical investigation.

The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas

S. Asa, S. Yamada, Y. Takeuchi, 2015, Endocrine Pathology.

The distinct role of the Runx proteins in chondrocyte differentiation and intervertebral disc degeneration: findings in murine models and in human disease.

H. Haro, S. Takeda, M. Osaki, 2008, Arthritis and rheumatism.

Vitamin K(2) inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures.

Y. Takeuchi, S. Fukumoto, T. Fujita, 2000, Bone.

A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis.

Y. Takeuchi, J. Silver, T. Fujita, 2005, The Journal of clinical endocrinology and metabolism.

Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.

S. Yamada, Y. Takeuchi, N. Inoshita, 2014, Journal of neurosurgery.

Hypoglycemic coma in a patient with anorexia nervosa coincident with acute exacerbation of liver injury induced by oral intake of nutrients.

Y. Takeuchi, A. Takeshita, M. Miyakawa, 2010, Internal medicine.

Cytokines suppress adipogenesis and PPAR-γ function through the TAK1/TAB1/NIK cascade

Kunihiro Matsumoto, H. Shibuya, Y. Gotoh, 2003, Nature Cell Biology.

Absence of mutations in parathyroid hormone (PTH)/PTH-related protein receptor complementary deoxyribonucleic acid in patients with pseudohypoparathyroidism type Ib.

E. Ogata, Y. Takeuchi, S. Fukumoto, 1996, The Journal of clinical endocrinology and metabolism.

Transsphenoidal cyst cisternostomy with a keyhole dural opening for sellar arachnoid cysts: technical note

S. Yamada, Y. Takeuchi, A. Takeshita, 2014, Neurosurgical Review.

A Case of Methimazole-Induced Acute Pancreatitis With an HLA Allele Causing Antithyroid Drug-Induced Agranulocytosis

Daisuke Hattori, Y. Takeuchi, A. Takeshita, 2022, Journal of the Endocrine Society.

Primary aldosteronism presenting with an atypical aldosterone-renin ratio in the acute phase of cerebral hemorrhage.

Y. Takeuchi, Hisanori Suzuki, N. Murakami, 2015, Internal medicine.

An adult patient with severe hypercalcaemia and hypocalciuria due to a novel homozygous inactivating mutation of calcium‐sensing receptor

S. Takeda, Toshio Matsumoto, Y. Takeuchi, 1999, Clinical endocrinology.

[Familial isolated hypoparathyroidism].

Y. Takeuchi, 2006, Nihon rinsho. Japanese journal of clinical medicine.

[A case of idiopathic portal hypertension supervening on SLE (systemic lupus erythematosus)--a study on the possible role of SLE in the pathogenesis of IPH].

Y. Takeuchi, M. Nagano, M. Kato, 1986, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Pitfalls in early biochemical evaluation after transsphenoidal surgery in patients with acromegaly.

S. Yamada, Y. Takeuchi, H. Nishioka, 2017, Endocrine journal.

Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia.

Y. Takeuchi, S. Fukumoto, T. Fujita, 1999, Bone.

Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade.

Kunihiro Matsumoto, H. Shibuya, Y. Gotoh, 2003, Nature cell biology.

Recurrence of primary hyperparathyroidism following spontaneous remission with intracapsular hemorrhage of a parathyroid adenoma

Y. Takeuchi, A. Takeshita, M. Miyakawa, 2008, Journal of Bone and Mineral Metabolism.

Therapeutic outcomes in patients undergoing surgery after diagnosis of Cushing's disease: A single-center study.

S. Yamada, Y. Takeuchi, N. Inoshita, 2015, Endocrine journal.

Therapeutic outcomes of transsphenoidal surgery in pediatric patients with craniopharyngiomas: a single-center study.

S. Yamada, Y. Takeuchi, N. Inoshita, 2018, Journal of neurosurgery. Pediatrics.

A Silent Follicle-Stimulating Hormone-Producing Pituitary Adenoma in a Teenage Male

T. Sano, S. Yamada, Y. Takeuchi, 2011, Endocrine pathology.

Short-term preoperative octreotide treatment for TSH-secreting pituitary adenoma.

S. Yamada, Y. Takeuchi, N. Inoshita, 2015, Endocrine journal.

Outcomes of three-Tesla magnetic resonance imaging for the identification of pituitary adenoma in patients with Cushing's disease.

S. Yamada, Y. Takeuchi, N. Inoshita, 2019, Endocrine journal.

A large functioning parathyroid cyst in a patient with multiple endocrine neoplasia type 1.

K. Ohashi, Y. Takeuchi, Hisanori Suzuki, 2013, Endocrine journal.

Differences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemia.

S. Takeda, Y. Takeuchi, S. Fukumoto, 1996, The Journal of clinical endocrinology and metabolism.

Coincidence of multiple endocrine neoplasia type 2A with acromegaly.

Y. Takeuchi, Tsunenori Saito, A. Takeshita, 2010, The American journal of the medical sciences.

The Interaction of Acute‐Phase Reaction and Efficacy for Osteoporosis After Zoledronic Acid: HORIZON Pivotal Fracture Trial

J. Cauley, I. Reid, Toshitaka Nakamura, 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic {beta}-cell function is preserved.

S. Yamada, Y. Takeuchi, H. Fujii, 2011, European journal of endocrinology.

1,25-dihydroxyvitamin D suppresses circulating levels of parathyroid hormone in a patient with primary hyperparathyroidism and coexistent sarcoidosis.

Y. Takeuchi, A. Takeshita, D. Miura, 2005, The Journal of clinical endocrinology and metabolism.

[Differential diagnosis of hypercalcemia].

Y. Takeuchi, 2007, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

6. New Progress of Bisphosphonate and New Drugs

Y. Takeuchi, 2008 .

[Current Topics on Vitamin D. Treatment of osteoporosis with eldecalcitol: Its therapeutic efficacy and adverse effect on renal function].

Y. Takeuchi, 2015, Clinical calcium.

Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period

R. Eastell, J. S. San Martin, S. Ralston, 2019, Calcified Tissue International.

Acute Phase Reactions After Intravenous Infusion of Zoledronic Acid in Japanese Patients with Osteoporosis: Sub-analyses of the Phase III ZONE Study

Toshitaka Nakamura, Y. Takeuchi, T. Sugimoto, 2021, Calcified Tissue International.

Retraction Note: Cytokines suppress adipogenesis and PPAR-γ function through the TAK1/TAB1/NIK cascade

Kunihiro Matsumoto, H. Shibuya, Y. Gotoh, 2014, Nature Cell Biology.

Self-Administration of Burosumab in Children and Adults with X-Linked Hypophosphataemia in Two Open-Label, Single-Arm Clinical Studies

K. Ozono, Y. Takeuchi, Y. Imanishi, 2023, Advances in Therapy.

Scalp hair loss after transsphenoidal adenomectomy in patients with acromegaly

S. Yamada, Y. Takeuchi, H. Nishioka, 2013, Clinical endocrinology.

[Parathyroid hormone (PTH)].

Y. Takeuchi, Y. Tamura, 1999, Nihon rinsho. Japanese journal of clinical medicine.

Challenges in the functional diagnosis of thyroid nodules before surgery for TSH-producing pituitary adenoma

S. Fukata, Y. Takeuchi, H. Nishioka, 2021, Endocrinology, diabetes & metabolism case reports.

Tumoral calcinosis in a patient with hypoparathyroidism, sensorineural deafness, and renal dysplasia syndrome undergoing hemodialysis

Y. Ubara, Y. Takeuchi, T. Tajima, 2015, Clinical Case Reports.

Cinacalcet hydrochloride relieves hypercalcemia in Japanese patients with parathyroid cancer and intractable primary hyperparathyroidism

Y. Takeuchi, Y. Tominaga, M. Katagiri, 2017, Journal of Bone and Mineral Metabolism.

Evocalcet in patients with primary hyperparathyroidism: an open-label, single-arm, multicenter, 52-week, dose-titration phase III study

Y. Takeuchi, Y. Imanishi, S. Fukumoto, 2020, Journal of Bone and Mineral Metabolism.